SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study. - Dopfer-Jablonka A; Steffens S; Müller F; Mikuteit M; Niewolik J; Cossmann A; Stankov MV; Behrens GMN; Hummers E; Heesen G; Schröder D; Roder S; et al. (BMC infectious diseases, 2022)